34
1
0
Like?
Please wait...
About This Project
70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
Developing a new tissue preservation method inspired by Tardigrades
There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...
Targeted Drug Delivery by using Magnetic Nanoparticles
What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...